Reni Benjamin
Stock Analyst at Citizens JMP
(0.05)
# 4,623
Out of 4,644 analysts
816
Total ratings
34.9%
Success rate
-9%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintained: Buy | $5 → $8 | $6.74 | +18.69% | 50 | Aug 7, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $396 → $405 | $359.05 | +12.80% | 11 | Aug 6, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | $35 → $41 | $21.30 | +92.49% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $4.71 | +69.85% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $5 → $8 | $2.07 | +286.47% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 → $8 | $4.06 | +97.04% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $0.3831 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Maintained: Buy | $3 → $6 | $5.73 | +4.71% | 15 | Mar 11, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $34 | $14.17 | +139.94% | 1 | Mar 9, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $11.37 | +102.29% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $31 | $24.63 | +25.86% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.3819 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $24.93 | +28.36% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.37 | +321.94% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $8 | $3.77 | +112.20% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.26 | - | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $9.94 | +141.45% | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $120.77 | - | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.38 | - | 23 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $15.10 | +164.90% | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.48 | - | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $98.36 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $30.42 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.50 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.17 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.95 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.029 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.02 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $70.24 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $1.10 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $57 | $49.00 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $10.91 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $0.8932 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $2.00 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.20 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $9.78 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $13 | $0.6579 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $49.50 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.3321 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.72 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.74 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.77 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.035 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0012 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.61 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $3.44 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $1.08 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $4.19 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.63 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.90 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.00001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.96 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $38.10 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $18.38 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.57 | n/a | 2 | Oct 12, 2010 |
Iovance Biotherapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $6.74
Upside: +18.69%
BeOne Medicines AG
Aug 6, 2026
Maintained: Buy
Price Target: $396 → $405
Current: $359.05
Upside: +12.80%
Sutro Biopharma
Apr 23, 2026
Maintained: Buy
Price Target: $35 → $41
Current: $21.30
Upside: +92.49%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.71
Upside: +69.85%
Allogene Therapeutics
Apr 14, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $2.07
Upside: +286.47%
Bicycle Therapeutics
Mar 18, 2026
Maintained: Buy
Price Target: $12 → $8
Current: $4.06
Upside: +97.04%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3831
Upside: -
Prelude Therapeutics
Mar 11, 2026
Maintained: Buy
Price Target: $3 → $6
Current: $5.73
Upside: +4.71%
Lyell Immunopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $14.17
Upside: +139.94%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $11.37
Upside: +102.29%
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $24.63
Upside: +25.86%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.3819
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $24.93
Upside: +28.36%
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.37
Upside: +321.94%
Oct 30, 2025
Maintained: Buy
Price Target: $5 → $8
Current: $3.77
Upside: +112.20%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.26
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $9.94
Upside: +141.45%
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $120.77
Upside: -
Sep 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.38
Upside: -
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $15.10
Upside: +164.90%
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.48
Upside: -
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $98.36
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $30.42
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.50
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $8.17
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $6.95
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.029
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: n/a
Current: $4.02
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $70.24
Upside: n/a
Mar 18, 2019
Maintained: Buy
Price Target: $6 → $5
Current: $1.10
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $73 → $57
Current: $49.00
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $10.91
Upside: n/a
Dec 13, 2018
Maintained: Buy
Price Target: $21
Current: $0.8932
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $2.00
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $3.20
Upside: n/a
Oct 12, 2018
Maintained: Buy
Price Target: $11 → $10
Current: $9.78
Upside: n/a
Aug 28, 2018
Maintained: Buy
Price Target: $13 → $13
Current: $0.6579
Upside: n/a
Aug 14, 2018
Maintained: Buy
Price Target: $22
Current: $49.50
Upside: n/a
Aug 10, 2018
Maintained: Hold
Price Target: n/a
Current: $0.3321
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $2.72
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $7.74
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $11.77
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.035
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0012
Upside: n/a
May 21, 2015
Maintained: Buy
Price Target: $8
Current: $1.61
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $3.44
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $1.08
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $4.19
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $1.63
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $6.90
Upside: n/a
Dec 11, 2014
Maintained: Buy
Price Target: $40
Current: $0.00001
Upside: n/a
Oct 13, 2014
Maintained: Hold
Price Target: n/a
Current: $1.96
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $38.10
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $18.38
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.57
Upside: n/a